Overview
Jean-luc Villeval practices in Villejuif, France. Mr. Villeval is rated as a Distinguished expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, Myelofibrosis, and Polycythemia Vera.
His clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Essential ThrombocythemiaMr. Villeval isDistinguished. Learn about Essential Thrombocythemia.
- MyelofibrosisMr. Villeval isDistinguished. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Mr. Villeval isDistinguished. Learn about Myeloproliferative Neoplasms (MPN).
- Polycythemia VeraMr. Villeval isDistinguished. Learn about Polycythemia Vera.
- Advanced
- SplenomegalyMr. Villeval isAdvanced. Learn about Splenomegaly.
- Experienced
- Blood ClotsMr. Villeval isExperienced. Learn about Blood Clots.
- Budd-Chiari SyndromeMr. Villeval isExperienced. Learn about Budd-Chiari Syndrome.
- Mesenteric Venous ThrombosisMr. Villeval isExperienced. Learn about Mesenteric Venous Thrombosis.
- ThrombophlebitisMr. Villeval isExperienced. Learn about Thrombophlebitis.